On the HCPLive Atopic Dermatitis condition center page, resources on the topics of medical news and expert insight into eczema can be found. Content includes articles, interviews, videos, podcasts, and breaking news on dermatitis research, treatment, and drug development.
April 25th 2024
This analysis highlighted several trends in search volume regarding eczema, including correlations with weather and climate.
Therapy for Difficult-to-Treat Skin Disease Now Available in Japan
Regeneron has announced that Dupixent, a therapy for adult atopic dermatitis (AD) that is inadequately controlled by existing medications, has been granted marketing and manufacturing authorization in Japan.